glp-1 medications tirzepatide Injectable | Compounded GLP-1/GIP GLP-1s appear to cut cancer
Description
One of the newest GLP-1s on the market, tirzepatide, is a dual-action agonist, targeting receptors on both the GLP-1 and GIP pathways
doi: 10.1097/MPA.0000000000000229
Zepbound dry mouth is a recognized side effect associated with changes in fluid intake, appetite regulation, and digestive signaling during GLP-1based weight management therapy
Many patients explore supplemental compounds like berberine alongside prescription metabolic medications to optimize glucose control and weight management
Glucagon is typically understood as a counter-regulatory hormone
Morales, A
